Literature DB >> 22036300

CaMKII antisense oligodeoxynucleotides protect against ischemia-induced neuronal death in the rat hippocampus.

Zhi'an Liu1, Jing Xu, Xiaojun Shen, Chun'e Lv, Tiejun Xu, Dongsheng Pei.   

Abstract

The present study was performed to investigate the effects of Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) antisense oligodeoxynucleotides (ODNs) on the assembly of the CaMKII·GluR6·PSD-95 signaling module, GluR6 serine phosphorylation and c-Jun N-terminal kinase 3 (JNK3) activation. A further aim was to determine the neuroprotective mechanism of CaMKII antisense ODNs against ischemia-reperfusion (I/R)-induced neuronal death in the rat hippocampus. CaMKII antisense ODNs were intracerebroventricularly infused to inhibit CaMKII expression once daily for 3 days prior to the induction of ischemia. Transient cerebral ischemia (15 min) and reperfusion were induced by four-vessel occlusion in Sprague-Dawley rats as an animal model for transient cerebral I/R. The expression of related proteins was examined by immunoprecipitation and immunoblotting. Neuronal death in the rat hippocampus was detected by histology and histochemistry. The results indicate that CaMKII antisense ODNs inhibit several of the processes that are normally induced by cerebral I/R, including CaMKII expression, increased CaMKII·GluR6·PSD-95 signaling module assembly, GluR6 serine phosphorylation and JNK3 activation. Alternatively, CaMKII antisense ODNs also exhibit a significant neuroprotective role against cerebral I/R-induced cell death. These results provide the first evidence that CaMKII antisense ODNs can exert neuroprotective effects on cerebral I/R-induced cell death. The possible molecular mechanisms underlying this effect include 1) an inhibition of CaMKII expression and subsequent suppression of the assembly of the CaMKII·GluR6·PSD-95 signaling module, 2) GluR6 serine phosphorylation, and 3) reduced JNK3 activation.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22036300     DOI: 10.1016/j.jns.2011.10.012

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  7 in total

1.  αCaMKII is differentially regulated in brain regions that exhibit differing sensitivities to ischemia and excitotoxicity.

Authors:  Kathryn A Skelding; Neil J Spratt; Lisa Fluechter; Phillip W Dickson; John A P Rostas
Journal:  J Cereb Blood Flow Metab       Date:  2012-08-29       Impact factor: 6.200

2.  Convergent Ca2+ and Zn2+ signaling regulates apoptotic Kv2.1 K+ currents.

Authors:  Meghan C McCord; Elias Aizenman
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-05       Impact factor: 11.205

3.  Tea polyphenols increase X-ray repair cross-complementing protein 1 and apurinic/apyrimidinic endonuclease/redox factor-1 expression in the hippocampus of rats during cerebral ischemia/reperfusion injury.

Authors:  Zhi Wang; Rongliang Xue; Xi Lei; Jianrui Lv; Gang Wu; Wei Li; Li Xue; Xiaoming Lei; Hongxia Zhao; Hui Gao; Xin Wei
Journal:  Neural Regen Res       Date:  2012-10-25       Impact factor: 5.135

Review 4.  Tissue-type plasminogen activator is a homeostatic regulator of synaptic function in the central nervous system.

Authors:  Valerie Jeanneret; Manuel Yepes
Journal:  Neural Regen Res       Date:  2017-03       Impact factor: 5.135

Review 5.  Role of Ca2+/Calmodulin-Dependent Protein Kinase Type II in Mediating Function and Dysfunction at Glutamatergic Synapses.

Authors:  Archana G Mohanan; Sowmya Gunasekaran; Reena Sarah Jacob; R V Omkumar
Journal:  Front Mol Neurosci       Date:  2022-06-20       Impact factor: 6.261

Review 6.  Biological Properties of JNK3 and Its Function in Neurons, Astrocytes, Pancreatic β-Cells and Cardiovascular Cells.

Authors:  Rei Nakano; Tomohiro Nakayama; Hiroshi Sugiya
Journal:  Cells       Date:  2020-07-29       Impact factor: 6.600

Review 7.  Calcium/Calmodulin-Dependent Protein Kinase II in Cerebrovascular Diseases.

Authors:  Xuejing Zhang; Jaclyn Connelly; Edwin S Levitan; Dandan Sun; Jane Q Wang
Journal:  Transl Stroke Res       Date:  2021-03-13       Impact factor: 6.829

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.